Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Diabetes > Opportunities Assessment for Diabetes Therapeutics - Australia
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Opportunities Assessment for Diabetes Therapeutics - Australia

Published by Frost & Sullivan
Published December, 2008 Product code 79387
Content info 53 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


Opportunities Assessment for Diabetes Therapeutics - Australia published by Frost & Sullivan in December, 2008. This report consists of 53 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Australia.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • Executive Summary

2. DIABETES MARKET

Market Overview

  • Introduction
  • Context for Study
  • Report Scope and Segmentation
  • Methodology
  • Restraints in Forecasts

3. AUSTRALIAN DIABETES MARKET

Market Overview

  • Introduction
  • Market Engineering Measurements
  • Government Initiatives
  • PBS Drug Listing Process

Market Forecasts and Trends

  • Patient Forecasts
  • Cost of Treatment

Treatment and Diagnosis

  • Key Treaters and Patient Flow
  • Diagnostic Tests and Monitoring
  • Treatment Options
  • Product Launches
  • Clinical Trials

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis
  • Future Trends
  • Challenges Faced by Physicians

4. APPENDIX

Australia

  • Australia
Back to Top